AIDS and other Immunodeficiencies cHAPTER 19 43 DEf rosine L-R (XHM) kinase (XLa) CD4OL CD40 Class lI mhc T cell B cell Defect in DEfective recombination- tivating genes f Class lI mhc RAG-1/2) FIGURE Defects in cell interaction and signaling can lead to of receptors for IL-2, 4, 7, 9, and 15(IL-RY): (3)JAK-3, which trans- severe immunodeficiency. The interaction of T cell and B cell is duces signals from the gamma chain of the cytokine receptor: or(4) shown here with a number of the components important to the intra- expression of the class ll MHC molecule(bare lymphocyte syn- and extracellular signaling pathways. A number of primary immuno- drome). XLA results from defective transduction of activating signals deficiencies are rooted in defects in these interactions. SCID may re- from the cell-surface IgM by Bruton's tyrosine kinase( Btk). XHM re- lt from defects in (1)the recombination-activating genes(RAG-1 sults from defects in CD40L that preclude normal maturation of B and) required for synthesis of the functional immunoglobulins and lls. Adapted from B. A. Smart and H. D. Ochs, 1997, Curr. Opin T-cell receptors that characterize mature B and T cells: (2)the y chain Pediatr. 9: 570. phenotype because the Il receptors signal through this mol- nucleoside phosphorylase(PNP)causes immunodeficiency ecule, accounted for 9 of the cases(see Figure 12-10). A rare by a mechanism similar to the ADa defect. As described in defect found in only 2 of the patients involved the IL-7 recep- Chapters 5 and 9, both immunoglobulin and T-cell receptor tor;these patients have impaired T and B cells but normal genes undergo rearrangement to express the active forms of NK cells. Another common defect is the adenosine deami- these molecules. a defect in the genes that encode mediators nase or ada deficiency found in 22 patients. Adenosine of the rearrangement processes (recombination-activating deaminase catalyzes conversion of adenosine to inosine, and proteins RAG-1 and RAG-2)precludes development of B and its deficiency results in accumulation of adenosine, which in- T cells with functional receptors and leads to SCID terferes with purine metabolism and DNA synthesis. The a defect leading to general failure of immunity similar to remaining cases included single instances of reticular dysge- SCID is failure to transcribe the genes that encode class II nesis and cartilage hair dysplasia or were classified as autos- MHC molecules. Without these molecules, the patient's lym- mal recessive defects not related to known IL-2Ry or JAK-3 phocytes cannot participate in cellular interactions with T mutations. Thirteen of the 141 cases were of unknown ori- helper cells. This type of immunodeficiency is also called the gin, with no apparent genetic defect or family history of im- bare-lymphocyte syndrome. Molecular studies of a class II munodeficien MHC deficiency revealed a defective interaction between a 5 There are other known defects that give rise to SCID. There promoter sequence of the gene for the class ll MHC molecule is a defect characterized by depletion of CD8* T cells that in- and a DNA-binding protein necessary for gene transcription. volves the tyrosine kinase ZAP-70, an important element in Other patients with SCID-like symptoms lack class I MHC T-cell signal transduction(see Figures 10-11 and 10-12). In- molecules. This rare variant of immunodeficiency was fants with defects in ZAP-70 may have normal levels of im- ascribed to mutation in the taP genes that are vital to anti- munoglobulin and CD4 lymphocytes, but their CD4 t gen processing by class I MHc molecules(see Clinical Focus cells are nonfunctional. a deficiency in the enzyme purine Chapter 8). This defect causes a deficit in CD8-mediatedphenotype because the IL receptors signal through this molecule, accounted for 9 of the cases (see Figure 12-10). A rare defect found in only 2 of the patients involved the IL-7 receptor; these patients have impaired T and B cells but normal NK cells. Another common defect is the adenosine deaminase or ADA deficiency found in 22 patients. Adenosine deaminase catalyzes conversion of adenosine to inosine, and its deficiency results in accumulation of adenosine, which interferes with purine metabolism and DNA synthesis. The remaining cases included single instances of reticular dysgenesis and cartilage hair dysplasia or were classified as autosomal recessive defects not related to known IL-2R or JAK-3 mutations. Thirteen of the 141 cases were of unknown origin, with no apparent genetic defect or family history of immunodeficiency. There are other known defects that give rise to SCID. There is a defect characterized by depletion of CD8 T cells that involves the tyrosine kinase ZAP-70, an important element in T-cell signal transduction (see Figures 10-11 and 10-12). Infants with defects in ZAP-70 may have normal levels of immunoglobulin and CD4 lymphocytes, but their CD4 T cells are nonfunctional. A deficiency in the enzyme purine nucleoside phosphorylase (PNP) causes immunodeficiency by a mechanism similar to the ADA defect. As described in Chapters 5 and 9, both immunoglobulin and T-cell receptor genes undergo rearrangement to express the active forms of these molecules. A defect in the genes that encode mediators of the rearrangement processes (recombination-activating proteins RAG-1 and RAG-2) precludes development of B and T cells with functional receptors and leads to SCID. A defect leading to general failure of immunity similar to SCID is failure to transcribe the genes that encode class II MHC molecules. Without these molecules, the patient’s lymphocytes cannot participate in cellular interactions with T helper cells. This type of immunodeficiency is also called the bare-lymphocyte syndrome. Molecular studies of a class II MHC deficiency revealed a defective interaction between a 5 promoter sequence of the gene for the class II MHC molecule and a DNA-binding protein necessary for gene transcription. Other patients with SCID-like symptoms lack class I MHC molecules. This rare variant of immunodeficiency was ascribed to mutation in the TAP genes that are vital to antigen processing by class I MHC molecules (see Clinical Focus Chapter 8). This defect causes a deficit in CD8-mediated AIDS and Other Immunodeficiencies CHAPTER 19 435 FIGURE 19-3 Defects in cell interaction and signaling can lead to severe immunodeficiency. The interaction of T cell and B cell is shown here with a number of the components important to the intraand extracellular signaling pathways. A number of primary immunodeficiencies are rooted in defects in these interactions. SCID may result from defects in (1) the recombination-activating genes (RAG-1 and -2) required for synthesis of the functional immunoglobulins and T-cell receptors that characterize mature B and T cells; (2) the chain of receptors for IL-2, 4, 7, 9, and 15 (IL-R); (3) JAK-3, which transduces signals from the gamma chain of the cytokine receptor; or (4) expression of the class II MHC molecule (bare lymphocyte syndrome). XLA results from defective transduction of activating signals from the cell-surface IgM by Bruton’s tyrosine kinase (Btk). XHM results from defects in CD40L that preclude normal maturation of B cells. [Adapted from B. A. Smart and H. D. Ochs, 1997, Curr. Opin. Pediatr. 9:570.] IL-2, IL-4, IL-7, IL-9, IL-15 IL-Rγ IL-Rγ Ag IgM Ig B7 CD28 CD4 Class II MHC CD40L CD40 TCR T cell B cell Btk RAG-1/2 RAG-1/2 JAK-3 Deficiency in JAK-3 pathway Defect in CD40L (XHM) Defect in Bruton's tyrosine kinase (XLA) Defect in recombinationactivating genes (RAG-1/2) Defective expression of Class II MHC (bare lymphocyte syndrome) Defect in γ chain of receptors for IL-2, 4, 7, 9, 15